The Effects of Aerobic Exercise on Parkinson's Disease
Primary Objective
This research study aims to learn more about the effects of aerobic exercise on people with Parkinson’s disease who have not yet started medication for their Parkinson's disease. It will compare the effects of moderate-intensity treadmill exercise to high-intensity treadmill exercise on the signs and symptoms of Parkinson’s disease.
Description
This is an exercise research study for people who have been recently diagnosed with Parkinson's disease.
Aerobic exercise is a vital treatment for people living with Parkinson's disease. Although anti-parkinsonian medication helps alleviate Parkinson's symptoms, it is not known to slow the rate of disease progression. Aerobic exercise is a treatment with the most compelling evidence for its potential to slow Parkinson's disease progression. While both moderate—and high-intensity aerobic exercise provide health benefits, it is currently unclear which intensity is more effective for people with Parkinson’s.
Main Procedures Involved: Participants will complete a telephone screening followed by two in-person screening visits to confirm that they meet the criteria to participate in the study. Once determined eligible, participants will be randomly assigned (like flipping a coin) to either a moderate-intensity exercise group or a high-intensity exercise group. Each group will walk on a treadmill 4 days a week for approximately 30 minutes at a location convenient to them. Throughout the study, participants will make periodic campus visits to meet with the study team for neurological and physical assessments, exercise testing, blood draws, and a brain scan.
Duration of Participation: This is a 2-year study consisting of 18 months of exercise, followed by monthly check-ins for 6 months.
Details
- Diagnosed with Parkinson's disease within the last 3 years
- Not yet taking medications for Parkinson's symptoms
- Not planning to start Parkinson's medications in the next 6 months.
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Cory Christiansen
Resources
Study ID
Protocol Number: 20-1854
More information available at ClinicalTrials.gov: NCT04284436
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers